These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 29969654)

  • 1. Depletion of astrocytic transglutaminase 2 improves injury outcomes.
    Monteagudo A; Feola J; Natola H; Ji C; Pröschel C; Johnson GVW
    Mol Cell Neurosci; 2018 Oct; 92():128-136. PubMed ID: 29969654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.
    Monteagudo A; Ji C; Akbar A; Keillor JW; Johnson GVW
    Biochem Biophys Res Commun; 2017 Jan; 482(4):942-947. PubMed ID: 27899316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.
    Feola J; Barton A; Akbar A; Keillor J; Johnson GVW
    Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Transglutaminase 2 from Mouse Astrocytes Significantly Improves Their Ability to Promote Neurite Outgrowth on an Inhibitory Matrix.
    Emerson J; Delgado T; Girardi P; Johnson GVW
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.
    Quinn BR; Yunes-Medina L; Johnson GVW
    J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
    Colak G; Johnson GV
    Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of astrocytic transglutaminase 2 facilitates the expression of a neurosupportive astrocyte reactive phenotype in association with increased histone acetylation.
    Delgado T; Emerson J; Hong M; Keillor JW; Johnson GV
    bioRxiv; 2024 Oct; ():. PubMed ID: 36798305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion or Inhibition of Astrocytic Transglutaminase 2 Promotes Functional Recovery after Spinal Cord Injury.
    Elahi A; Emerson J; Rudlong J; Keillor JW; Salois G; Visca A; Girardi P; Johnson GVW; Pröschel C
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.
    Yunes-Medina L; Feola J; Johnson GVW
    Neuroreport; 2017 Dec; 28(18):1208-1214. PubMed ID: 28957946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of astrocytic transglutaminase 2 facilitates the expression of a neurosupportive astrocyte reactive phenotype in association with increased histone acetylation.
    Delgado T; Emerson J; Hong M; Keillor JW; Johnson GV
    bioRxiv; 2024 Nov; ():. PubMed ID: 38659783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.
    Espitia Pinzón N; Brevé JJP; Bol JGJM; Drukarch B; Baron W; van Dam AM
    J Neuroinflammation; 2017 Dec; 14(1):260. PubMed ID: 29282083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?
    van Strien ME; Brevé JJ; Fratantoni S; Schreurs MW; Bol JG; Jongenelen CA; Drukarch B; van Dam AM
    PLoS One; 2011; 6(9):e25037. PubMed ID: 21949843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system.
    Rudlong J; Cheng A; Johnson GVW
    Anal Biochem; 2020 Feb; 591():113556. PubMed ID: 31866289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
    Filiano AJ; Bailey CD; Tucholski J; Gundemir S; Johnson GV
    FASEB J; 2008 Aug; 22(8):2662-75. PubMed ID: 18375543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viability.
    Yunes-Medina L; Paciorkowski A; Nuzbrokh Y; Johnson GVW
    Mol Cell Neurosci; 2018 Jan; 86():72-80. PubMed ID: 29197584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone.
    Yin X; Feng L; Ma D; Yin P; Wang X; Hou S; Hao Y; Zhang J; Xin M; Feng J
    J Neuroinflammation; 2018 Mar; 15(1):97. PubMed ID: 29587860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination.
    Espitia Pinzon N; Sanz-Morello B; Brevé JJ; Bol JG; Drukarch B; Bauer J; Baron W; van Dam AM
    Sci Rep; 2017 Jan; 7():40995. PubMed ID: 28128219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.
    Gundemir S; Colak G; Feola J; Blouin R; Johnson GV
    Biochim Biophys Acta; 2013 Jan; 1833(1):1-10. PubMed ID: 23085038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
    Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
    J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.